Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Expert Review of Clinical Immunology|March 16, 2018
Epratuzumab for the treatment of systemic lupus erythematosusDaniel Geh, Caroline GordonEssays in Biochemistry|August 3, 2023
Harnessing neutrophil plasticity for HCC immunotherapyErik Ramon-Gil, Daniel Geh, Jack LeslieHepatobiliary Surgery and Nutrition|February 12, 2021
Hepatocellular carcinoma in non-alcoholic fatty liver disease-a review of an emerging challenge facing cliniciansDaniel Geh, Derek M Manas, Helen L ReevesJournal of Hepatocellular Carcinoma|January 23, 2019
Weighing the benefits of hepatocellular carcinoma surveillance against potential harmsDaniel Geh, Fahd A Rana, Helen L ReevesJournal of Hepatocellular Carcinoma|April 15, 2021
NAFLD-Associated HCC: Progress and OpportunitiesDaniel Geh, Quentin M Anstee, Helen L ReevesJournal of Hepatology|February 14, 2022
Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactionsJack Leslie, Daniel Geh, Ahmed M Elsharkawy, et al.Nature Reviews. Gastroenterology & Hepatology|January 13, 2022
Neutrophils as potential therapeutic targets in hepatocellular carcinomaDaniel Geh, Jack Leslie, Rob Rumney, et al.Nature Reviews. Gastroenterology & Hepatology|November 17, 2025
Improving surgical treatments for hepatocellular carcinomaAbdullah K Malik, Daniel Geh, Thomas R Jeffry Evans, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2021
Latent Cytomegalovirus Infection and Previous Capsular Polysaccharide Vaccination Predict Poor Vaccine Responses in Older Adults, Independent of Chronic Kidney DiseaseNadezhda Wall, Alexandra Godlee, Daniel Geh, et al.Journal of Hepatology|January 9, 2016
Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1Hannah C Jeffery, Bonnie van Wilgenburg, Ayako Kurioka, et al.Pageof 2